-
1
-
-
66949117423
-
The scientific and clinical basis for the treatment of Parkinson disease (2009)
-
Olanow C.W., Stern M.B., Sethi K. The scientific and clinical basis for the treatment of Parkinson disease (2009). Neurology 2009, 72:S1-S136.
-
(2009)
Neurology
, vol.72
-
-
Olanow, C.W.1
Stern, M.B.2
Sethi, K.3
-
2
-
-
61949226675
-
Treatments for Parkinson disease - past achievements and current clinical needs
-
Poewe W. Treatments for Parkinson disease - past achievements and current clinical needs. Neurology 2009, 72:S65-S73.
-
(2009)
Neurology
, vol.72
-
-
Poewe, W.1
-
3
-
-
0030749473
-
Levodopa with benserazide or carbidopa in Parkinson disease
-
Dingemanse J., Kleinbloesem C.H., Zurcher G., Wood N.D., Crevoisier C. Levodopa with benserazide or carbidopa in Parkinson disease. Br. J. Clin. Pharmacol. 1997, 44:41-48.
-
(1997)
Br. J. Clin. Pharmacol.
, vol.44
, pp. 41-48
-
-
Dingemanse, J.1
Kleinbloesem, C.H.2
Zurcher, G.3
Wood, N.D.4
Crevoisier, C.5
-
4
-
-
1642435344
-
Levodopa with benserazide or carbidopa in Parkinson disease
-
Shen H., Kannari K., Yamato H., Arai A., Mtsunaga M. Levodopa with benserazide or carbidopa in Parkinson disease. Tohoku J. Exp. Med. 2003, 199:149-159.
-
(2003)
Tohoku J. Exp. Med.
, vol.199
, pp. 149-159
-
-
Shen, H.1
Kannari, K.2
Yamato, H.3
Arai, A.4
Mtsunaga, M.5
-
5
-
-
0023637175
-
Inhibition of decarboxylase and levels of dopa and 3-O-methyldopa: a comparative study of benserazide versus carbidopa in rodents and of Madopar standard versus Madopar HBS in volunteers
-
Da Prada M., Kettler R., Zurcher G., Shaffner R., Haefely W.E. Inhibition of decarboxylase and levels of dopa and 3-O-methyldopa: a comparative study of benserazide versus carbidopa in rodents and of Madopar standard versus Madopar HBS in volunteers. Eur. Neurol. 1987, 27:9-20.
-
(1987)
Eur. Neurol.
, vol.27
, pp. 9-20
-
-
Da Prada, M.1
Kettler, R.2
Zurcher, G.3
Shaffner, R.4
Haefely, W.E.5
-
6
-
-
0018639137
-
Levodopa with benserazide or carbidopa in Parkinson disease
-
Rinne U.K., Molsa P. Levodopa with benserazide or carbidopa in Parkinson disease. Neurology 1979, 12:1584-1589.
-
(1979)
Neurology
, vol.12
, pp. 1584-1589
-
-
Rinne, U.K.1
Molsa, P.2
-
7
-
-
0028296588
-
Simultaneous determination of levodopa methyl ester, levodopa, 3-O-methyldopa and dopamine in plasma by high-performance liquid chromatography with electrochemical detection
-
Rondelli I., Acerbi D., Mariotti F., Ventura P. Simultaneous determination of levodopa methyl ester, levodopa, 3-O-methyldopa and dopamine in plasma by high-performance liquid chromatography with electrochemical detection. J. Chromatogr. B 1994, 653:17-23.
-
(1994)
J. Chromatogr. B
, vol.653
, pp. 17-23
-
-
Rondelli, I.1
Acerbi, D.2
Mariotti, F.3
Ventura, P.4
-
8
-
-
0034064565
-
Simultaneous determination of levodopa, carbidopa and their metabolites in human plasma and urine samples using LC-EC
-
Sagar K.A., Smyth M.R. Simultaneous determination of levodopa, carbidopa and their metabolites in human plasma and urine samples using LC-EC. J. Pharm. Biomed. Anal. 2000, 22:613-624.
-
(2000)
J. Pharm. Biomed. Anal.
, vol.22
, pp. 613-624
-
-
Sagar, K.A.1
Smyth, M.R.2
-
9
-
-
1342328125
-
Simultaneous determination of levodopa and 3-O-methyldopa in human plasma by liquid chromatography with electrochemical detection
-
Saxer C., Niina M., Nakashima A., Nagae Y., Masuda N. Simultaneous determination of levodopa and 3-O-methyldopa in human plasma by liquid chromatography with electrochemical detection. J. Chromatogr. B 2004, 802:299-305.
-
(2004)
J. Chromatogr. B
, vol.802
, pp. 299-305
-
-
Saxer, C.1
Niina, M.2
Nakashima, A.3
Nagae, Y.4
Masuda, N.5
-
10
-
-
33646253888
-
Modified high-performance liquid chromatography with electrochemical detection method for plasma measurement of levodopa, 3-O-methyldopa, dopamine, carbidopa and 3,4-dihydroxyphenyl acetic acid
-
Karimi M., Carl J.L., Loftin S., Perlmutter J.S. Modified high-performance liquid chromatography with electrochemical detection method for plasma measurement of levodopa, 3-O-methyldopa, dopamine, carbidopa and 3,4-dihydroxyphenyl acetic acid. J. Chromatogr. B 2006, 836:120-123.
-
(2006)
J. Chromatogr. B
, vol.836
, pp. 120-123
-
-
Karimi, M.1
Carl, J.L.2
Loftin, S.3
Perlmutter, J.S.4
-
11
-
-
43049149420
-
Simultaneous determination of serum concentrations of levodopa, dopamine, 3-O-methyldopa and a-methyldopa by HPLC
-
Muzzi C., Bertocci E., Terzuoli L., Porcelli B., Ciari I., Pagani R., Guerranti R. Simultaneous determination of serum concentrations of levodopa, dopamine, 3-O-methyldopa and a-methyldopa by HPLC. Biomed. Pharmacother. 2008, 62:253-258.
-
(2008)
Biomed. Pharmacother.
, vol.62
, pp. 253-258
-
-
Muzzi, C.1
Bertocci, E.2
Terzuoli, L.3
Porcelli, B.4
Ciari, I.5
Pagani, R.6
Guerranti, R.7
-
12
-
-
35348953710
-
Simultaneous kinetic-spectrophotometric determination of carbidopa, levodopa and methyldopa in the presence of citrate with the aid of multivariate calibration and artificial neural networks
-
Chamsaz M., Safavi A., Fadaee J. Simultaneous kinetic-spectrophotometric determination of carbidopa, levodopa and methyldopa in the presence of citrate with the aid of multivariate calibration and artificial neural networks. Anal. Chim. Acta 2007, 603:140-146.
-
(2007)
Anal. Chim. Acta
, vol.603
, pp. 140-146
-
-
Chamsaz, M.1
Safavi, A.2
Fadaee, J.3
-
13
-
-
77949288102
-
Quantitative analysis of levodopa, carbidopa and methyldopa in human plasma samples using HPLC-DAD combined with second-order calibration based on alternating trilinear decomposition algorithm
-
Li S.F., Wu H.L., Yu Y.J., Li Y.N., Nie J.F., Fu H.Y., Yu R.Q. Quantitative analysis of levodopa, carbidopa and methyldopa in human plasma samples using HPLC-DAD combined with second-order calibration based on alternating trilinear decomposition algorithm. Talanta 2010, 81:805-812.
-
(2010)
Talanta
, vol.81
, pp. 805-812
-
-
Li, S.F.1
Wu, H.L.2
Yu, Y.J.3
Li, Y.N.4
Nie, J.F.5
Fu, H.Y.6
Yu, R.Q.7
-
14
-
-
0042697374
-
Quantitative high throughput analysis of drugs in biological matrices by mass spectrometry
-
Hopfgartner G., Bourgogne E. Quantitative high throughput analysis of drugs in biological matrices by mass spectrometry. Mass Spectrom. Rev. 2003, 22:195-214.
-
(2003)
Mass Spectrom. Rev.
, vol.22
, pp. 195-214
-
-
Hopfgartner, G.1
Bourgogne, E.2
-
15
-
-
25844504983
-
Critical review of development, validation and transfer for high throughput bioanalytical LC-MS/MS methods
-
Zhou S., Song Q., Tang Y., Naidong W. Critical review of development, validation and transfer for high throughput bioanalytical LC-MS/MS methods. Curr. Pharm. Anal. 2005, 1:3-14.
-
(2005)
Curr. Pharm. Anal.
, vol.1
, pp. 3-14
-
-
Zhou, S.1
Song, Q.2
Tang, Y.3
Naidong, W.4
-
16
-
-
77954864483
-
Simultaneous determination of L-dopa and its prodrug (S)-4-(2-acetamido-3-ethoxy-3-oxopropyl)-1,2-phenylene diacetate in rat plasma by high-performance liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study
-
Jiang W., Lv L., Zhou S., Huang X., Shi X., Lv C., Wu L., Xu C. Simultaneous determination of L-dopa and its prodrug (S)-4-(2-acetamido-3-ethoxy-3-oxopropyl)-1,2-phenylene diacetate in rat plasma by high-performance liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study. J. Pharm. Biomed. Anal. 2010, 53:751-754.
-
(2010)
J. Pharm. Biomed. Anal.
, vol.53
, pp. 751-754
-
-
Jiang, W.1
Lv, L.2
Zhou, S.3
Huang, X.4
Shi, X.5
Lv, C.6
Wu, L.7
Xu, C.8
-
17
-
-
0037784168
-
Determination of cabergoline and L-dopa in human plasma using liquid chromatography-tandem mass spectrometry
-
Igarashi K., Hotta K., Kasuya F., Abe K., Sakoda S. Determination of cabergoline and L-dopa in human plasma using liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 2003, 792:55-61.
-
(2003)
J. Chromatogr. B
, vol.792
, pp. 55-61
-
-
Igarashi, K.1
Hotta, K.2
Kasuya, F.3
Abe, K.4
Sakoda, S.5
-
18
-
-
0034672538
-
Development and validation of a semi-automated method for L-dopa and dopamine in rat plasma using electrospray LC/MS/MS
-
Li W., Rossi D.T., Fountain S.T. Development and validation of a semi-automated method for L-dopa and dopamine in rat plasma using electrospray LC/MS/MS. J. Pharm. Biomed. Anal. 2000, 24:325-333.
-
(2000)
J. Pharm. Biomed. Anal.
, vol.24
, pp. 325-333
-
-
Li, W.1
Rossi, D.T.2
Fountain, S.T.3
-
19
-
-
79955492001
-
LC-MS-MS simultaneous determination of L-dopa and its prodrug L-dopa n-pentyl ester hydrochloride in rat plasma
-
Lv L., Jiang W., Zhou S., Huang X., Shi X., Lv C., Wu L., Xu C. LC-MS-MS simultaneous determination of L-dopa and its prodrug L-dopa n-pentyl ester hydrochloride in rat plasma. Chromatographia 2010, 72:239-243.
-
(2010)
Chromatographia
, vol.72
, pp. 239-243
-
-
Lv, L.1
Jiang, W.2
Zhou, S.3
Huang, X.4
Shi, X.5
Lv, C.6
Wu, L.7
Xu, C.8
-
20
-
-
0023861032
-
A new method for the determination of L-dopa and 3-O-methyldopa in plasma and cerebrospinal fluid using gas chromatography and electron capture negative ion mass spectrometry
-
De Jong A.P.J.M., Kok R.M., Cramers C.A., Wadman S.K., Haan E. A new method for the determination of L-dopa and 3-O-methyldopa in plasma and cerebrospinal fluid using gas chromatography and electron capture negative ion mass spectrometry. Clin. Chim. Acta 1988, 171:49-61.
-
(1988)
Clin. Chim. Acta
, vol.171
, pp. 49-61
-
-
De Jong, A.P.J.M.1
Kok, R.M.2
Cramers, C.A.3
Wadman, S.K.4
Haan, E.5
-
21
-
-
2342523744
-
-
U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Rockville
-
Food and Drug Administration. FDA Guidance for Industry: Bioanalytical Method Validation 2001, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Rockville.
-
(2001)
Food and Drug Administration. FDA Guidance for Industry: Bioanalytical Method Validation
-
-
-
22
-
-
84856526460
-
-
Agência Nacional de Vigilância Sanitária. Manual de Boas Práticas em Biodisponibilidade e Bioequivalência, Gerência Geral de Inspeção e Controle de Medicamentos e Produtos, Brasília,
-
Agência Nacional de Vigilância Sanitária. Manual de Boas Práticas em Biodisponibilidade e Bioequivalência, vol. 1, Gerência Geral de Inspeção e Controle de Medicamentos e Produtos, Brasília, 2002.
-
(2002)
, vol.1
-
-
|